These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 21161281)

  • 1. Not ready for prime time: aliskiren for treatment of hypertension or proteinuria in children.
    Flynn JT
    Pediatr Nephrol; 2011 Mar; 26(3):491-2. PubMed ID: 21161281
    [No Abstract]   [Full Text] [Related]  

  • 2. Aliskiren (Tekturna) a new weapon to battle the silent killer.
    Laustsen G
    Nurse Pract; 2007 Jul; 32(7):6-7. PubMed ID: 17595578
    [No Abstract]   [Full Text] [Related]  

  • 3. Are we ready to use aliskiren in children?
    Kelland EE; McAuley LM; Filler G
    Pediatr Nephrol; 2011 Mar; 26(3):473-7. PubMed ID: 21153557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renin inhibition with aliskiren in hypertension: focus on aliskiren/hydrochlorothiazide combination therapy.
    Sureshkumar KK
    Vasc Health Risk Manag; 2008; 4(6):1205-20. PubMed ID: 19337534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and pharmacodynamics of aliskiren, an oral direct renin inhibitor.
    Buczko W; Hermanowicz JM
    Pharmacol Rep; 2008; 60(5):623-31. PubMed ID: 19066408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aliskiren: clinical experience and future perspectives of renin inhibition.
    Sureshkumar KK; Vasudevan S; Marcus RJ; Hussain SM; McGill RL
    Expert Opin Pharmacother; 2008 Apr; 9(5):825-37. PubMed ID: 18345958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aliskiren, the future of renin-angiotensin system blockade?
    Uresin Y; Mehtar Bozkurt M; Sabirli S; Ozunal ZG
    Expert Rev Cardiovasc Ther; 2007 Sep; 5(5):835-49. PubMed ID: 17867914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aliskiren, the first in a new class of direct renin inhibitors for hypertension: present and future perspectives.
    Oh BH
    Expert Opin Pharmacother; 2007 Nov; 8(16):2839-49. PubMed ID: 17956203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of pharmacokinetic interactions of aliskiren, a novel direct renin inhibitor for the treatment of hypertension, with the antihypertensives amlodipine, valsartan, hydrochlorothiazide (HCTZ) and ramipril in healthy volunteers.
    Vaidyanathan S; Valencia J; Kemp C; Zhao C; Yeh CM; Bizot MN; Denouel J; Dieterich HA; Dole WP
    Int J Clin Pract; 2006 Nov; 60(11):1343-56. PubMed ID: 17073832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aliskiren in the management of hypertension.
    Barrios V; Escobar C
    Am J Cardiovasc Drugs; 2010; 10(6):349-58. PubMed ID: 21090828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and pharmacodynamics of aliskiren/hydrochlorothiazide single-pill combination tablets and free combination of aliskiren and hydrochlorothiazide.
    Yan JH; Jarugula V; Sabo R; Papst CC; Zhang J; Dole WP
    J Clin Pharmacol; 2012 May; 52(5):645-55. PubMed ID: 21659626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic, pharmacodynamic and clinical evaluation of aliskiren for hypertension treatment.
    Reboldi G; Gentile G; Angeli F; Verdecchia P
    Expert Opin Drug Metab Toxicol; 2011 Jan; 7(1):115-28. PubMed ID: 21105865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aliskiren: a review of its use in the management of hypertension.
    Frampton JE; Curran MP
    Drugs; 2007; 67(12):1767-92. PubMed ID: 17683174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aliskiren: an oral direct renin inhibitor for the treatment of hypertension.
    Sanoski CA
    Pharmacotherapy; 2009 Feb; 29(2):193-212. PubMed ID: 19170589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aliskiren: a new drug for an old problem.
    Barrios V; Escobar C
    Cardiovasc Hematol Agents Med Chem; 2010 Jan; 8(1):1-10. PubMed ID: 20210772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aldosterone breakthrough during aliskiren, valsartan, and combination (aliskiren + valsartan) therapy.
    Bomback AS; Rekhtman Y; Klemmer PJ; Canetta PA; Radhakrishnan J; Appel GB
    J Am Soc Hypertens; 2012; 6(5):338-45. PubMed ID: 22995802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics, safety, and tolerability of the oral Renin inhibitor aliskiren in patients with hepatic impairment.
    Vaidyanathan S; Warren V; Yeh C; Bizot MN; Dieterich HA; Dole WP
    J Clin Pharmacol; 2007 Feb; 47(2):192-200. PubMed ID: 17244770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aliskiren for renin inhibition: a new class of antihypertensives.
    Van Tassell BW; Munger MA
    Ann Pharmacother; 2007 Mar; 41(3):456-64. PubMed ID: 17341529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The development of the direct renin inhibitor aliskiren: treating hypertension and beyond.
    Siragy H; Huang J; Lieb DC
    Expert Opin Emerg Drugs; 2008 Sep; 13(3):417-30. PubMed ID: 18764720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of aliskiren in Japanese hypertensive patients with renal dysfunction.
    Ito S; Nakura N; Le Breton S; Keefe D
    Hypertens Res; 2010 Jan; 33(1):62-6. PubMed ID: 19927154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.